| 2024-03-07 | Sale | AxoGen, Inc. AXGN | director | 25,000 0.0581% | $9.00 | $225,000 | -22.39% | |
| 2023-06-01 | Sale | AxoGen, Inc. AXGN | director | 41,980 0.0994% | $8.71 | $365,780 | -18.63% | |
| 2023-05-23 | Sale | AxoGen, Inc. AXGN | director | 7,468 0.0176% | $9.23 | $68,899 | -21.55% | |
| 2022-11-14 | Sale | AxoGen, Inc. AXGN | director | 13,000 0.0339% | $12.74 | $165,620 | -27.03% | |
| 2022-11-08 | Sale | AxoGen, Inc. AXGN | director | 13,000 0.0337% | $12.50 | $162,500 | -25.66% | |
| 2022-08-10 | Sale | AxoGen, Inc. AXGN | 8,886 0.0204% | $9.70 | $86,159 | -4.15% | ||
| 2022-08-04 | Sale | AxoGen, Inc. AXGN | 13,046 0.0305% | $10.37 | $135,287 | -7.77% | ||
| 2021-06-15 | PDS Biotechnology Corporation PDSB | 5,882 0.0235% | $8.50 | $49,997 | -2.5% | |||
| 2021-02-25 | Sale | AxoGen, Inc. AXGN | director | 48,000 0.1208% | $22.06 | $1.06M | -23.83% | |
| 2020-12-29 | Sale | AxoGen, Inc. AXGN | director | 1,832 0.0023% | $8.90 | $16,314 | +8.43% | |
| 2020-12-21 | Sale | AxoGen, Inc. AXGN | director | 758 0.0018% | $16.42 | $12,446 | +11.1% | |
| 2018-11-30 | Sale | AxoGen, Inc. AXGN | General Counsel | 90,000 0.2389% | $33.00 | $2.97M | -46.33% | |
| 2018-11-15 | Sale | AxoGen, Inc. AXGN | General Counsel | 40,000 0.1053% | $32.25 | $1.29M | -42.98% | |
| 2014-06-03 | AxoGen, Inc. AXGN | CFO | 400 0.0023% | $2.34 | $936 | +28.09% | ||
| 2014-06-02 | AxoGen, Inc. AXGN | CFO | 10,000 0.0605% | $2.45 | $24,500 | +27.8% | ||
| 2013-08-14 | AxoGen, Inc. AXGN | CFO | 16,668 0.1176% | $3.00 | $50,004 | +16.33% | ||
| 2011-12-30 | AxoGen, Inc. AXGN | CFO | 18,636 0.448% | $2.40 | $44,726 | +7.41% | ||
| 2011-11-22 | AxoGen, Inc. AXGN | CFO | 18,000 0.493% | $2.92 | $52,500 | +0.69% | ||
| 2011-11-21 | AxoGen, Inc. AXGN | CFO | 12,000 0.3287% | $2.90 | $34,760 | +1.4% |